If a patient shows improvement with lifestyle changes (e.g., a lowered ALT level and, if relevant, lowered triglyceride and/or HbA1c levels, alongside weight loss), a confirmatory test may not be needed, as the parallel improvements in several measures lend strong confidence to the diagnosis of NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.